Endolumik Gastric Calibration Tube (EGCT) for Obesity

N/A

Waitlist Available

Research Sponsored by Endolumik, Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days post surgical treatment

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a glowing tube that helps doctors see better during weight-loss surgeries. It is aimed at bariatric patients having sleeve gastrectomy or gastric bypass operations. The tube lights up the stomach area, improving visibility for surgeons.

Eligible Conditions

Obesity

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during surgical treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during surgical treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and during surgical treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

30-day morbidity

Intraoperative adverse events

Operative time

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Bariatric SurgeryExperimental Treatment1 Intervention

Up to twenty participants meeting inclusion criteria will undergo laparoscopic or robotic sleeve gastrectomy using the Endolumik Gastric Calibration Tube instead of the standard bougie calibration tube. Up to ten participants meeting inclusion criteria will undergo laparoscopic gastric bypass using the Endolumik Gastric Calibration Tube instead of the standard calibration tube.

Do I qualify?Apply below to find out